Patrícia Silva, PhD, director of science content — 
Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
Articles by Patrícia Silva
Recent Posts
- Blood GFAP levels linked to AAV disease activity, kidney involvement November 13, 2024
- 2 self-reactive antibodies linked to higher relapse risk in AAV in study November 6, 2024
- Phase 3 trial of Tavneos enrolling children, ages 6-17, with AAV November 4, 2024
- Fasenra granted approval in EU for hard-to-treat EGPA patients October 30, 2024
- Combo maintentance therapy found more effective in severe EGPA October 28, 2024
- Alivexis’ MOD06051 shows promise as AAV therapy in rat model October 23, 2024
- Low ceruloplasmin protein linked to worse survival in anti-MPO AAV October 21, 2024
- ADX-097, potential AAV therapy, fares well in healthy volunteers October 16, 2024
- Long-term Nucala for EGPA eases disease activity, improves survival October 14, 2024
- Vasculitis Foundation launches new support group for young adults October 9, 2024